Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Allergic Rhinitis and Conjunctivitis
•
Primary Care
When do you consider lifelong AIT?
Related Questions
What methods have you found successful in getting young children to use nasal sprays?
Do you retest for environmental aeroallergens when patients have relocated within the US between vastly different climates?
Do you look for local IgE production in the nares with negative SPT and IgE testing if the clinical history suggests AR and the patient desires AIT?
How do you manage recurrent epistaxis from nasal steroids?
Do you routinely take a cancer history from patients being evaluated for atopy?
Does a diagnosis of NARES change your management of rhinitis?
How long would you treat severe eosinophilic asthma/pneumonia with q4week anti-IL5 therapy prior to tapering?
Do you recommend patients try antihistamines such as oral ketotifen that are not approved in the US but are approved in the EU for MCAS if currently available formulations have not been effective?
Do mRNA vaccines lead to increased rates of acute/chronic urticaria?
Do you recommend lifelong antibiotic prophylaxis, or do you prefer a more selective approach based on risk factors in asplenic patients without a history of severe infections?
